ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0014792 | Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. | Blood Cells, Red|Red Blood Cells|Blood erythrocytic cell|Blood Erythrocyte|Red Cell|Erythrocytic Cells|rbcs|Marrow erythrocyte|red blood cell|Blood red cell|Blood Corpuscle, Red|Corpuscle, Red Blood|erythrocyte|Erythrocytes|erythrocytes|RBC|cells red blood|Corpuscles, Red Blood|Erythrocyte (cell)|Normocyte|blood erythrocytes|Anucleate erythrocyte|Blood Cell, Red|Blood erythrocyte|Erythrocyte, NOS|erythrocytic|red blood corpuscle|Red blood corpuscle|Red Blood Corpuscles|Erythrocytic|Red cell of marrow|blood corpuscle|blood cells rbc red|Reticuloendothelial System, Erythrocytes|bloods cells red|blood corpuscles red|Red Blood Cell|Red blood cell|red blood cells|RBCs|Erythrocyte|ERYTHROCYTES|Blood Corpuscles, Red|Red Blood Corpuscle|RBC - Red blood cell|Red blood corpuscule|Red cells|Blood normocyte | Erythrocytes |
C1136254 | Any substance or process that kills germs (bacteria, viruses, and other microorganisms that can cause infection and disease). | ANTIMICROBIALS|microbicides|Agents, Anti-Microbial|Antimicrobial Agent [TC]|Anti Microbial Agents|antimicrobial|Antimicrobial Agent|Microbicide|Microbicides|microbicide|Antimicrobial|antimicrobials|antimicrobial drug|Anti-Microbial Agents|Antimicrobial Agents|Agents, Antimicrobial|antimicrobial agent | Microbicides |
C0028115 | A 34-amino acid polypeptide antibiotic produced by Streptococcus lactis. It has been used as a food preservative in canned fruits and vegetables, and cheese. | Nisin|nisin | Nisin |
C0030956 | Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES. | Peptide|Peptide, NOS|peptides|Product containing peptide (product)|Peptide-containing product|Peptide (substance)|Peptides|peptide | Peptides |
C0242358 | Cell-cell junctions that seal adjacent epithelial cells together, preventing the passage of most dissolved molecules from one side of the epithelial sheet to the other. (Alberts et al., Molecular Biology of the Cell, 2nd ed, p22) | Occluden, Zonula|Zonula Occluden|Occluding Junction|tight junction|occluding cell junction|Junctions, Tight|Tight Junction|Occludens, Zonula|Tight junction (cell structure)|Junctions, Occluding|bicellular tight junction|occluding junction|zonula occludens|tight junctions|junctions tight|Occluding cell junction|Zonula Occludens|Junction, Occluding|Close junction|Junction, Tight|Zonula occludens|Occluding Junctions|Tight junction|Tight Junctions | Tight Junctions |
C0007526 | A genus of the family CEBIDAE, subfamily CEBINAE, consisting of gracile or untufted capuchin species. Tufted capuchins belong to genus SAPAJUS. Members include C. capucinus, C. nigrivultatus, and C. albifrons. Cebus inhabits the forests of Central and South Americas. | Ring-Tail Monkey|Monkey, Ringtail|Gracile Capuchins|Ringtailed Monkeys|Sapajou|Capuchin Monkey|Cebus, NOS|Ringtail Monkey|Capuchin, Gracile|Monkey, Ring Tailed|Ring-Tail Monkeys|Genus Cebus|Capuchin, White-Fronted|Monkey, Capuchin|White Fronted Capuchin|Monkey, Ring-Tailed|Capuchin monkey, NOS|Ring-Tailed Monkey|White-Fronted Capuchins|White-Fronted Capuchin|Monkey, Ring-Tail|Capuchin monkeys|capuchin|Capuchin, Untufted|Untufted Capuchin|Monkey, Ringtailed|Untufted Capuchins|Genus Cebus (organism)|Ringtailed Monkey|Monkey, Ring Tail|Capuchin Monkeys|Cebus|Ringtail Monkeys|Gracile Capuchin|Capuchin monkey|Ring-Tailed Monkeys | Capuchin Monkey |
C0162783 | The rostral part of the frontal lobe, bounded by the inferior precentral fissure in humans, which receives projection fibers from the MEDIODORSAL NUCLEUS OF THE THALAMUS. The prefrontal cortex receives afferent fibers from numerous structures of the DIENCEPHALON; MESENCEPHALON; and LIMBIC SYSTEM as well as cortical afferents of visual, auditory, and somatic origin. | prefrontal cortex|PREFRONTAL CORTEX|Prefrontal association cortex|Cortex, Prefrontal|prefrontal lobe|Prefrontal cortex|Prefrontal Cortex|cortex prefrontal | Prefrontal Cortex |
C0999514 | null | Brown capuchin monkey|Cebus apella|brown-capped capuchin|Cebus apella (organism)|brown capuchin|Cebus brunneus|Sapajus apella|Cebus albifrons trinitatis|black-capped capuchin | Cebus brunneus |
C0162772 | Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. | pro oxidant|active oxygen|oxygen radicals|oxygen reactive species|Oxygen Radical|ROS|Reactive Oxygen Species|Active Oxygen|Oxygen, Active|reactive oxygen species|oxygen radical|Oxygen Species, Reactive|Oxygen Radicals|Pro Oxidants|Active oxygen|Pro-Oxidants | Reactive Oxygen Species |
C0037473 | A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. | Sodium 23|Na|Sodium (substance)|sodium|na sodium|SODIUM|Sodium|Sodium-23|Sodium, NOS|Sodium (NOS)|Na - Sodium|Na element | sodium |
C0038734 | Compounds containing the -SH radical. | Compounds, Sulfhydryl|mercaptans|Compounds, Mercapto|Sulphydryl|Sulfhydryl|thiols|groups sulfhydryl|mercaptan|Thiols|Mercaptans|sulfhydryl group|Sulfhydryl (substance)|sulfhydryl|sulphydryl|thiol|Mercapto Compounds | Sulfhydryl Compounds |
C0682685 | The narrow gap that separates the presynaptic and postsynaptic membranes, into which neurotransmitter is released. [GOC:jl, http://synapses.mcg.edu/anatomy/chemical/synapse.stm] | clefts synaptic|Synaptic cleft|synaptic cleft|Synaptic Cleft | Synaptic cleft |
C0220839 | null | glutamate|Glutamate|Glu|Glutamate (substance)|L Glutamate|l-glutamate|L-Glutamate | glutamate |
C0017725 | A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. | Dextrosa|d-Glucose preparation|Dextrose, Unspecified Form|D-glucose|D-Glucose|Dextrose, unspecified form|Dextrose preparation|Glucose (substance)|Glucose|glucose|endocrine glucose|D-glucose preparation|dextrose|glucose preparations|Glucose-containing product|Dextrose, unspecified|D Glucose|Glucose preparation|Glucose, NOS|DEXTROSE|glucoses|6-(hydroxymethyl)oxane-2,3,4,5-tetrol|D(+)-Glucose|DEXTROSE, UNSPECIFIED FORM|dextrose, unspecified form|GLUCOSE|Dextrose, Unspecified form|Product containing glucose (medicinal product)|d-glucose|Glucosa|D-glucopyranose monohydrate preparation|Grape sugar|Dextrose | glucose |
C0030054 | An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. | O<sub>2</sub>|Oxygen, NOS|Oxygen|O2|Oxygen USP|O|Elemental oxygen|Chemical oxygen|Oxygen-16|Oxygen-containing product|oxygen|OXYGEN|O element|o 2|Pure oxygen|Oxygen 16|Product containing oxygen (medicinal product)|O2 element|Oxygen (substance)|O>2<|O2 - oxygen | oxygen |
C0017817 | A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. | GLUTATHIONE|Glutathione, NOS|gamma L Glu L Cys Gly|gamma-L-Glu-L-Cys-Gly|5-L-Glutamyl-L-cysteinylglycine|L-Glutathione|N-(N-L-gamma-glutamyl-L-cysteinyl)glycine|Glutathione|gamma L Glutamyl L Cysteinylglycine|Glutathione-SH|Glutathione-containing product|glutathiones|Product containing glutathione (medicinal product)|glutathione|gamma-L-Glutamyl-L-Cysteinylglycine|gamma-L-Glutamyl-L-cysteinyl-glycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|Glutathione (substance)|GSH|Glycine, N-(N-L-gamma-glutamyl-L-cysteinyl)- | glutathione |
C0080138 | 8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-3- benzazepin-7-ol; D2 dopamine antagonist and tranquilizer. | SCH-23390|SCH23390|SCH 23390 | SCH 23390 |
C0038803 | A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed) | (±)-sulpiride|Sulpiridum|N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-5-Sulfamoyl-O-Anisamide|N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpiride-containing product|sulperide|Sulpiride (substance)|sulpiride|Benzamide, 5-(Aminosulfonyl)-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-2-Methoxy-|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpirida|Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-|Product containing sulpiride (medicinal product)|SULPIRIDE|Sulperide|Sulpirid|Sulpyrid|Sulpiride | sulpiride |
C0655655 | null | 6-AMFL | 6-(aminomethyl)fluorescein |
C0655655 | null | 6-AMFL | 6-(aminomethyl)fluorescein |
C0655655 | null | 6-AMFL | 6-(aminomethyl)fluorescein |
C0370231 | null | Whole blood (substance)|Whole blood preparation, NOS|Whole blood preparation|Whole blood|Whole blood product|whole blood|Whole blood product (product)|blood whole | whole blood |
C0023810 | Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) | Lipopolysaccharide (substance)|Lipoglycans|Lipopolysaccharide, NOS|Lipopolysaccharide|lipopolysaccharide (LPS)|lps|lipopolysaccharides|LPS|lipopolysaccharide|Lipopolysaccharides | Lipopolysaccharides |
C0027882 | The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. | neurons|neural cell|Neurons|cells neural|Neuron|Neurocyte|Neural cell|Nerve cell|nerve cells|Cell, Nerve|Neurone|Neural Cell|Nerve Cells|Cells, Nerve|Nerve Cell|Neuron, NOS|nerve cell|neurone|cells nervous system|Neuron (cell)|nerve unit|neuron|nervous system cell|neurocyte | Neurons |
C0037533 | null | Sodium Nitroprusside|Sodium nitroprusside (substance)|nitroprusside sodium|Sodium nitroferricyanide|Sodium nitroprusside|Disodium Salt Nitroprusside|Nitroprusside, Sodium|Nitroprusside, Disodium Salt|sodium nitroprusside|Nitroprusside, sodium|SODIUM NITROPRUSSIDE | sodium nitroprusside |
C0028128 | A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. | endothelial cell derived relaxing factor|óxido de nitrógeno(II)|Vasodilator, Endogenous Nitrate|óxido nítrico|Endogenous Nitrate Vasodilator|Oxyde nitrique|nitric oxides|Nitric oxide-containing product|Oxide, Nitric|Stickstoff(II)-oxid|endothelium-derived relaxing factor|Product containing nitric oxide (medicinal product)|Nitrogen monoxide|edrf|Monoxide, Mononitrogen|Nitric oxide|NITRIC OXIDE|EDRF|nitric oxide|nitrogen protoxide|Nitric Oxide, Endothelium Derived|Stickstoffmonoxid|Nitrate Vasodilator, Endogenous|Nitric oxide (substance)|Monoxide, Nitrogen|Nitrogen Oxide|Nitrogen oxide (NO)|Endothelium-Derived Relaxing Factor|Monoxyde d'azote|Nitric Oxide|Mononitrogen Monoxide|Nitrogen Monoxide|Nitric Oxide, Endothelium-Derived|Endothelium-Derived Nitric Oxide|Monóxido de nitrógeno|NO - Nitric oxide|Nitrosyl|Mononitrogen monoxide|NO|Nitric oxide gas|Nitrogen monooxide|Oxyde azotique | nitric oxide |
C1510438 | A laboratory test to find and measure the amount of a specific substance. | assay|Assay technique|Assay technique (qualifier value)|Assay | Assay |
C0600437 | A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) | Nitric Oxide Donors|nitric oxide donors|Donors, Nitric Oxide|nitric oxide donor|Oxide Donors, Nitric | Nitric Oxide Donors |
C0070002 | null | null | panaxydol |
C0812581 | null | null | Laparoscopic Procedures on the Ureter |
C0812581 | null | null | Laparoscopic Procedures on the Ureter |
C0070002 | null | null | panaxydol |
C0040300 | Collections of differentiated CELLS, such as EPITHELIUM; CONNECTIVE TISSUE; MUSCLES; and NERVE TISSUE. Tissues are cooperatively arranged to form organs with specialized functions such as RESPIRATION; DIGESTION; REPRODUCTION; MOVEMENT; and others. | body tissue|Normal Tissue|Body Tissues|tissue|Textus|Body tissue structure (body structure)|Body tissue structure|body tissues|Body tissue|Tissue|tissues|Tissues|TISSUE|Portion of tissue|Tissue, NOS|Body tissue, NOS | Body tissue |
C0205094 | Of or involving the front of a main body. | front|FORE|Anterior (qualifier value)|fronts|Front of|anterior|Front|Fore|Anterior|ANTERIOR|of front|Front (qualifier value) | Anterior |
C0025543 | Proteases which use a metal, normally ZINC, in the catalytic mechanism. This group of enzymes is inactivated by metal CHELATORS. | metalloprotease|Metalloproteinase (substance)|Metalloproteinases|Metalloproteases|metalloproteinases|Metalloproteinase|metalloproteases|Metallopeptidases|Metallopeptidase|METALLOPROTEASE|metallopeptidase|metalloproteinase (general)|metalloproteinase | Metalloproteases |
C0282641 | Genes that are introduced into an organism using GENE TRANSFER TECHNIQUES. | Transgene|transgene|Transgenes | Transgenes |
C0238286 | An autosomal recessive lysosomal storage disease caused by mutations in the MCOLN1 gene. It is characterized by psychomotor developmental delays and ophthalmologic abnormalities. | Type IV Mucolipidoses|MUCOLIPIDOSIS IV|SIALOLIPIDOSIS|Sialolipidoses|Mucolipidosis IV|Mucolipidosis, Type IV|ML4|Ganglioside sialidase deficiency|Sialolipidosis|mucolipidosis iv|mucolipidosis type iv|Mucolipidosis Type IV|ML IV|Mucolipidosis type IV|Mucolipidosis type IV (disorder)|Deficiency Disease, Ganglioside Sialidase|Ganglioside Sialidase Deficiency Disease|Type IV Mucolipidosis|Mucolipidoses, Type IV | Mucolipidosis Type IV |
C0024369 | A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured. Such rupture is supposed to be under metabolic (hormonal) control. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) | Lysosome|Lysosome, NOS|lysosome|lysosoma|lysosomes|Lysosome (cell structure)|Lysosoma|Lysosomes | Lysosomes |
C1335144 | A gene from one species which corresponds to a gene in another species that is related via a common ancestral species (a homologous gene), but which has evolved to become different from the gene of the other species. | Ortholog | Orthologous Gene |
C0175648 | null | mat|mats | Mats |
C0162415 | Mesodermal tissue or tissue with mesodermal origin. | Mesenchyme|mesenchyma|mesenchyme|Mesenchymas | Mesenchyma |
C1284009 | It lies next to the neural tube and will form SOMITES. | Dorsal Mesoderms|Mesoderm, Dorsal|Mesoderms, Paraxial|Paraxial mesoderm (body structure)|Paraxial Mesoderms|Dorsal Mesoderm|Paraxial Mesoderm|Mesoderm, Paraxial|Mesoderms, Dorsal|Paraxial mesoderm | Paraxial Mesoderm |
C0029974 | A mature haploid female germ cell extruded from the OVARY at OVULATION. | Ovum (cell)|Ovum structure|Egg|Egg, Unfertilized|female gamete|Female gamete|Human egg|female gametes|X-bearing ovum|Ova (qualifier value)|ovum|egg cell|Mature ovum|Ovum, NOS|X bearing ovum|Egg, NOS|Unfertilized Egg|Ovum structure (cell structure)|human egg|Ovum|Oocytes|Eggs, Unfertilized|Human Oocyte (Egg)|X chromosome-bearing ovum|Ova|egg/ovum|ova|Unfertilized Eggs|Fertilized oocyte | Ovum |
C0598312 | The process by which a DNA molecule is duplicated. | DNA synthesis|Deoxyribonucleic acid replication|DNA replication|DNA Replication|synthesis dna|DNA Synthesis|dna synthesis|dna replications|deoxyribonucleic acid synthesis|DNA biosynthesis|DNA Replications|Replications, DNA|replication|dna replication|Replication|Replication, DNA|Deoxyribonucleic acid replication (finding) | DNA Replication |
C0043544 | The fertilized OVUM resulting from the fusion of a male and a female gamete. | Fertilized Egg|Fertilized ovum|Zygotes|egg fertilized|egg fertilizing|Zygote|Structure of zygote (cell structure)|Fertilized Ovum|Fertilised ovum|Ovum, Fertilized|eggs fertilizing|zygotes|zygote|Eggs, Fertilized|Structure of zygote|Fertilized Eggs|Fertilized Ovums|egg fertilize|Egg, Fertilized|fertilized egg|fertilized ovum | Structure of zygote |
C1281590 | null | Entire head|Entire head (body structure) | Entire head |
C0014144 | The inner of the three germ layers of an embryo. | Endoderm structure (body structure)|endoderm|Endoderms|Endoderm|Endoderm, NOS|Endoderm structure | Endoderm |
C0051804 | null | 5-(1-methyl-2-piperidinyl)-2,3'-bipyridine | anabasamine |
C0231067 | One of a series of paired endodermal evaginations, located on either side of the embryonic pharyngeal foregut between the pharyngeal arches, that each differentiate to form different components of the head and neck. | Pharyngeal Pouch|pharyngeal pouch|Pharyngeal pouch, NOS|Pharyngeal pouch|Branchial pouch | Pharyngeal pouch |
C0006899 | null | Infection, Capillaria philippinensis|Capillaria philippinensis Infections|Infection by Capillaria philippinensis|Intestinal capillariasis|Capillariasis, Intestinal|Capillariases, Intestinal|Intestinal Capillariases|Capillaria philippinensis infection|Capillaria philippinensis infection (disorder)|CAPILLARIASIS, INTESTINAL|Intestinal Capillariasis | Capillaria philippinensis Infection |
C1332253 | An intestinal-type adenoma arising from the ampulla of Vater. It is characterized by the presence of tubular and villous epithelial structures and it is associated with dysplasia. | null | Ampulla of Vater Tubulovillous Adenoma |
C1332253 | An intestinal-type adenoma arising from the ampulla of Vater. It is characterized by the presence of tubular and villous epithelial structures and it is associated with dysplasia. | null | Ampulla of Vater Tubulovillous Adenoma |
C0035305 | Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12). | Detachments, Retinal|retinal detachments|DETACHMENT RETINAL|Detachment, Retinal|Retina Detachment|RETINAL DETACHMENT|Retinal detachment|retina detached|RETINA, SEPARATION|Retinal detachment, NOS|Detached retina|retinal detachment|detached retina|RETINA, DETACHMENT|Retinal Detachments|RD - Retinal detachment|Detached Retina|RETINA DETACHMENT|Retinal detachment (disorder)|DETACHMENT, RETINA|Retinal detachments|Retinal Detachment|Sensory retinal detachment|retina detachment|Retina, Detached|Unspecified retinal detachment | Retinal Detachment |
C0042903 | Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma. | vitrectomy|Vitrectomy (procedure)|Vitrectomies|vitrectomies|Vitrectomy, NOS|vitrectomy procedure|Vitrectomy|Excision of vitreous opacity, NOS|Excision of vitreous opacity | Vitrectomy |
C0154830 | Advanced retinopathy due to diabetes mellitus characterized by the formation of new vessels in the retina. The new vessels are abnormal and fragile. If hemorrhage occurs due to the vascular fragility, there is increased risk of vision loss or blindness. | proliferative diabetic retinopathy (PDR)|proliferative diabetic retinopathy|Proliferative diabetic retinopathy|PDR - proliferative diabetic retinopathy|Proliferative retinopathy due to diabetes mellitus|Proliferative retinopathy due to diabetes mellitus (disorder)|Proliferative Diabetic Retinopathy|Proliferative retinopathy with diabetes mellitus | Proliferative diabetic retinopathy |
C0008562 | Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. | High performance liquid chromatography measurement, NOS|hplc|High pressure liquid chromatography (procedure)|High performance liquid chromatography measurement|high pressure liquid chromatography|Chromatography, Liquid, High Pressure|Chromatography, High Speed Liquid|High performance liquid chromatography measurement (procedure)|HPLC measurement|high performance liquid chromatography|High pressure liquid chromatography|Chromatography, High Performance Liquid|High Performance Liquid Chromatography|High pressure liquid chromatography (qualifier value)|High performance liquid chromatography|high pressure liquid chromatography (HPLC)|HPLC - High pressure liquid chromatography|HPLC measurement, NOS|HPLC|Chromatography, High Pressure Liquid | High pressure liquid chromatography procedure |
C0015392 | The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light. | Eyeball|Eyeball structure|Oculus|Structure of eye proper (body structure)|eyeballs|eyeball|Ophthalmic|EYE|Ocular structure|Eye, NOS|ocular|globe|ophthalmic|Structure of eye proper|Optic|Bulbus oculi|Eye|Ocular|Eyes|eye|Eye structure|eyes | Eye |
C0039350 | A conditionally essential nutrient, important during mammalian development. It is present in milk but is isolated mostly from ox bile and strongly conjugates bile acids. | Taurine|Product containing taurine (medicinal product)|Taufon|Taurineold|taufon|Tauphon|taurine|Taurine-containing product|Taurine (substance)|Ethanesulfonic acid, 2-amino-|Aminoethylsulfonic acid|TAURINE | taurine |
C0035298 | The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent. | Inner layer of eyeball|RETINA|Tunica interna of eyeball|Retinal structure|Tunica interna bulbi|Retina|retina|Retina, NOS|Retinal|retinas|retinal|Retinal structure (body structure) | Retina |
C0035309 | Diseases involving the RETINA. | RETINOPATHY|Unspecified retinal disorder|Retinopathy|Noninflammatory retina disease|diseases retinal|Retinal disorder, NOS|Retinal Disorders|Retinal disease|Retinal disorder (disorder)|Retinal disorder|Diseases, Retinal|Retinal disease, NOS|retinal diseases|retinal disease|RETINAL DISORDER|Disease, Retinal|Retinal Disorder|retinopathies|retinopathy|DISORDER RETINAL|disease retinal|disorders retina|Retinal Diseases|Retinopathy, NOS|disorders retinal|Retinal Disease|retina disorder|retinal disorder | Retinal Diseases |
C0042789 | The series of events required for an organism to receive a visual stimulus, convert it to a molecular signal, and recognize and characterize the signal. Visual stimuli are detected in the form of photons and are processed to form an image. [GOC:ai] | Visual function|functions visual|vision|sees|Vision, NOS|sense of sight|Vision|Visual function (observable entity)|Ocular Vision|visual function|Vision, Ocular|visions|Visual function, NOS|see|Sight|sensory visual perception|Ocular|VISION|visual perception|seeing | Vision |
C0042338 | The type species of VARICELLOVIRUS causing CHICKENPOX (varicella) and HERPES ZOSTER (shingles) in humans. | Varicellae, Herpesvirus|Chickenpox Viruses|Herpes Zoster Virus|Varicella virus|Human herpesvirus 3|human alphaherpesvirus 3|Herpesvirus 3, Human|Human alphaherpesvirus 3|HHV3|Human herpes virus 3|Ocular Herpes zoster Virus|VZV - Varicella-zoster virus|Human herpesvirus 3 (organism)|Herpes zoster|varicella virus|varicella-zoster virus VZV|Varicella-Zoster Virus 1|herpes zoster|Herpes zoster virus|Varicella-Zoster Viruses|VZV|varicella zoster virus VZV|chickenpox virus|Herpes zoster Viruses|Herpesvirus Varicellae|Herpes zoster Virus|Human (alpha) herpes virus 3|Herpesvirus 3 (alpha), Human|varicella-zoster virus|varicella zoster virus|Herpesvirus varicellae|HUMAN HERPESVIRUS 3|HZ - Herpes zoster|herpes zoster virus|Chickenpox Virus|Varicella-Zoster Virus|Varicella-zoster virus|VZ Virus|herpesvirus 3, human|HZ - Herpes zoster virus|VZ Viruses|HHV-3|Human Herpesvirus 3|VARICELLA|Varicella Zoster Virus | herpesvirus 3, human |
C0438734 | null | Fluid sample|Fluid specimen|Fluid sample (specimen) | Fluid specimen |
C0206558 | A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. | simplexvirus|Herpesvirus facialis|Simplexvirus species|Herpesvirus|Homini, Herpesvirus|Herpesvirus labialis|Genus Simplexvirus (organism)|Herpes simplex virus|herpes simplex virus|HSV|HSV - Herpes simplex virus|Virus, Herpes Labialis|SIMPLEXVIRUS|labialis herpes virus|HS - Herpes simplex|Simplexviruses|herpes simplex viruses|Herpes Simplex Viruses|Labialis Virus, Herpes|Simplexvirus, NOS|Herpesvirus, NOS|hsv|Herpesvirus Homini|Genus Simplexvirus|herpes virus simplex|Simplexvirus|Viruses, Herpes Labialis|Herpes Labialis Virus|Herpesvirus hominis|Herpes Labialis Viruses|Herpesvirus Hominis|herpesvirus|Labialis Viruses, Herpes|Herpes Simplex Virus|simplex virus herpes|Hominis, Herpesvirus | Simplexvirus |
C0003320 | Substances that are recognized by the immune system and induce an immune reaction. | Antigens|antigens|Immunogen, NOS|antigen|Antigen, NOS|immunogen|Antigen (substance)|Antigen|ag|immunogens | Antigens |
C0039194 | Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. | t-lymphocyte|T-Cell|T Cell Lymphocyte|T cell|t-cell|T-cell|t cell|Lymphocyte, Thymus-Dependent|Lymphocytes, Thymus-Dependent|T lymphocyte (cell)|t-cells|T Cells|T lymphocyte|T-Cells|t-lymphocytes|Thymus Derived Lymphocyte|T-lymphocyte|T-Lymphocytes|t lymphocyte|Thymus Dependent Lymphocytes|t cells|T Cell|Thymus-Dependent Lymphocyte|thymus-dependent lymphocyte|Thymus-Dependent Lymphocytes|t lymphocytes|T cells|T-Lymphocyte|T Lymphocytes|thymus derived lymphocyte | T-Lymphocyte |
C0021740 | A recombinant therapeutic agent which is chemically identical to or similar to the endogenous lymphokine interferon gamma (IFN-gamma) with antineoplastic, immunoregulatory, and antiviral activities. Therapeutic IFN-gamma binds to and activates the cell-surface IFN-gamma receptor, stimulating antibody-dependent cytotoxicity and enhances natural killer cell attachment to tumor cells. This agent also activates caspases, thereby inducing apoptosis in malignant cells. (NCI04) | Interferon Gamma (BIO)|Interferon Gamma|Recombinant Interferon Gamma|Gamma-Interferon|recombinant interferon gamma|Gamma Interferon (GEN)|IFN-g|Interferon, Gamma|Ginterferon|Gamma Interferon-SCH | Recombinant Interferon-gamma |
C0206679 | The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions. | human herpesvirus 1 group|human herpes virus 1|herpes virus 1, human|Human alphaherpesvirus 1|Human Herpesvirus 1|herpes simplex virus 1|herpes simplex virus type 1 HSV1|Human herpesvirus type 1|hsv-1|herpes simplex virus type 1 HSV-1|Herpesvirus 1 (alpha), Human|herpes simplex virus HSV-1|herpes simplex type 1 virus|Herpes Simplex Virus Type 1|human alphaherpesvirus 1|herpes simplex i|HSV-1|HSV 1|HHV1|Human (alpha) herpes virus 1|herpes simplex virus 1 HSV-1|HUMAN HERPESVIRUS 1|herpes simplex 1 virus|hsv i|Herpes simplex virus 1|virus type 1 herpes simplex|hhv-1|herpes simplex 1 virus (hsv-1)|hsv 1|1 hsv|herpes simplex virus type-1 HSV-1|Human herpes simplex virus type 1 (organism)|Herpes Simplex Virus 1|herpesvirus 1, human|1 herpes simplex virus|HHV-1|HSV 1 - Herpes simplex virus 1|herpes simplex virus type 1|Human herpesvirus 1|Herpesvirus 1, Human|HSV1|Human herpes simplex virus type 1|herpes virus simplex type 1 | herpesvirus 1, human |
C0042164 | Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed) | Uveitis (disorder)|UVEITIS|uveitis|Uveitis, NOS|Uveal inflammation|Uveitis NOS|Uveitis|Uveitides|Intraocular inflammation | Uveitis |
C0007600 | Established cell cultures that have the potential to propagate indefinitely. | cultured cell line|Cell Lines|cultured cells|cells lining|cell line|Cell lines|Cell Line|cells line|cells lines|Line, Cell|Lines, Cell|cell lines|cell lining | Cultured Cell Line |
C0035331 | A carotenoid constituent of visual pigments. It is the oxidized form of retinol which functions as the active component of the visual cycle. It is bound to the protein opsin forming the complex rhodopsin. When stimulated by visible light, the retinal component of the rhodopsin complex undergoes isomerization at the 11-position of the double bond to the cis-form; this is reversed in "dark" reactions to return to the native trans-configuration. | retinaldehyde|Aldehyde, Vitamin A|retinene|RETINAL, ALL-TRANS|Retinyl Aldehyde|retinal (bacteriorhodopsin)|Retinaldehyde (substance)|Retinene|Vitamin A Aldehyde|Retinal|retinal|Axerophthal|Retinaldehyde | Retinaldehyde |
C0015230 | Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. | rashes|exanthemata|SKIN ERUPTION|Rashes|cutaneous eruptions|ERUPTION|Skin Rash|Rash, Skin|Skin rashes|Exanthema|Cutaneous eruption, NOS|Rash, NOS|Skin rash|exanthem|RASH|efflorescence|Eruption of skin (disorder)|Rash|Rash and other nonspecific skin eruption|exanthems|Skin Eruption|Skin eruption|Exanthem|spots|cutaneous eruption on skin|Eruption|rash|skin rash|Cutaneous Eruption|skin eruption|Eruption of skin|Breaking out - eruption|exanthemas|exanthema|EXANTHEM|Exanthemata | Exanthema |
C0033684 | Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. | Protein (substance)|Protein|gene product|protein|PROTEINS|proteins|PROTEIN|Protein-containing product|Proteins|Protein, NOS|Protein (NOS)|Product containing protein (product) | Proteins |
C0228071 | A type of interneuron that conveys information to the brain. | Ganglion Cell|ganglion cell|Ganglion cell|Ganglion Cells|cells ganglion|gangliocyte|Ganglion cell (cell) | Ganglion cell |
C1512785 | null | null | Inner Plexiform Layer |
C1523372 | The inner segment of a vertebrate photoreceptor containing mitochondria, ribosomes and membranes where opsin molecules are assembled and passed to be part of the outer segment discs. [GOC:add, PMID:12019563] | photoreceptor inner segment | Inner segment of photoreceptor |
C0035322 | The single layer of pigment-containing epithelial cells in the RETINA, situated closely to the tips (outer segments) of the RETINAL PHOTORECEPTOR CELLS. These epithelial cells are macroglia that perform essential functions for the photoreceptor cells, such as in nutrient transport, phagocytosis of the shed photoreceptor membranes, and ensuring retinal attachment. | Pigmented layer of retina|Epithelium, Retinal Pigment|RPE|Outer pigmented layer of retina|Structure of retinal pigment epithelium|Pigment Epithelium, Retinal|pigment cell layer retina|epithelium pigmented retinal|epithelium pigment retinal|Stratum pigmentosum (Retina)|retinal pigment epithelium|RETINAL PIGMENTED EPITHELIAL LAYER|Structure of retinal pigment epithelium (body structure)|Pigment epithelium of retina|Stratum pigmentosum retinae|Retina, pigment epithelium|Retinal Pigment Epithelium|Retinal pigment epithelium|Pigmented retinal epithelium | Structure of retinal pigment epithelium |
C1153197 | Enables the transfer of a solute from one side of a membrane to the other, up its concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction and is driven by a chemiosmotic source of energy, not direct ATP coupling. Secondary active transporters include symporters and antiporters. [GOC:mtg_transport, ISBN:0198506732, ISBN:0815340729, PMID:10839820] | porter activity|coupled carrier|secondary active transmembrane transporter activity|secondary carrier-type facilitators|porters|electrochemical potential-driven transporter activity | porter activity |
C0599161 | A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. | reverse transcriptase polymerase chain reaction|reverse transcriptase-polymerase chain reaction|Polymerase Chain Reaction, Reverse Transcriptase|PCR, Reverse Transcriptase|Reverse Transcriptase PCR|RT PCR|rtpcr|reverse transcriptase pcr|Reverse Transcription Polymerase Chain Reaction|reverse transcription polymerase chain reaction|Transcriptase PCR, Reverse|Reverse Transcriptase-Polymerase Chain Reaction|reverse transcriptase PCR|rt-pcr|RT-PCR|rt pcr|REVERSE TRANSCRIPTASE PCR | Reverse Transcriptase Polymerase Chain Reaction |
C0073192 | A fluorescent probe with low toxicity which is a potent substrate for ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 and the bacterial multidrug efflux transporter. It is used to assess mitochondrial bioenergetics in living cells and to measure the efflux activity of ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 1 in both normal and malignant cells. (Leukemia 1997;11(7):1124-30) | Xanthylium, 3,6-diamino-9-(2-(methoxycarbonyl)phenyl)-, chloride | Rhodamine 123 |
C0008972 | A work that reports on the results of a research study to evaluate interventions or exposures on biomedical or health-related outcomes. The two main types of clinical studies are interventional studies (clinical trials) and observational studies. While most clinical studies concern humans, this publication type may be used for clinical veterinary articles meeting the requisites for humans. | clinical study|Study|clinical studies|CLINICAL STUDY|Clinical Study|Clinical Studies|Clinical Research|clinical research | Clinical Research |
C0242383 | A condition in which there is a slow breakdown of cells in the center of the retina (the light-sensitive layers of nerve tissue at the back of the eye). This blocks vision in the center of the eye and can cause problems with activities such as reading and driving. Age-related macular degeneration is most often seen in people who are over the age of 50. | age-related macular degeneration|Age Related Maculopathies|AMD|Age Related Maculopathy|Age-related macular degeneration (disorder)|age related maculopathy|Age-Related Maculopathy|AMD - Age-related macular degeneration|senile macular degeneration|Age-Related Macular Degeneration|Maculopathies, Age-Related|Age related macular degeneration|Macular degeneration, age-related|Maculopathy, Age-Related|Macular Degeneration|macular degeneration|Senile macular degeneration|Senile macular degeneration of retina, unspecified|age-related maculopathy|AAMD - Age related macular degeneration|Macular degeneration (senile), unspecified|Maculopathy, Age Related|Age-related macular degeneration|age related macular degeneration (ARMD)|ARMD (age related macular degeneration)|Age-Related Maculopathies|Macular degeneration (senile) of retina, unspecified|ARMD|MACULOPATHY, AGE-RELATED|age related macular degeneration|ARMD - Age-related macular degeneration|Macular Degeneration, Age-Related|Age Related Macular Degeneration|Senile macular retinal degeneration|Senile macular retinal degeneration, NOS|Macular Degeneration, Age Related|Age-Related Macular Degenerations|SMD - Senile macular degeneration | Age related macular degeneration |
C0663448 | null | Viagra | Viagra |
C0663448 | null | Viagra | Viagra |
C0724693 | A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION. | Sildenafil Citrate|1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate|Sildenafil citrate (substance)|Sildenafil citrate|SILDENAFIL CITRATE|Citrate, Sildenafil|sildenafil citrate | sildenafil citrate |
C0529793 | A drug used to treat erectile dysfunction. Sildenafil relaxes the smooth muscle of the penis to allow increased blood flow and erection. It is a type of phosphodiesterase inhibitor. | Sildenafilo|1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine|SILDENAFIL|sildenafil|Sildenafil (substance)|Sildenafil|Product containing sildenafil (medicinal product)|Sildenafil-containing product | sildenafil |
C0724693 | A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION. | Sildenafil Citrate|1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate|Sildenafil citrate (substance)|Sildenafil citrate|SILDENAFIL CITRATE|Citrate, Sildenafil|sildenafil citrate | sildenafil citrate |
C0035327 | Central retinal vein and its tributaries. It runs a short course within the optic nerve and then leaves and empties into the superior ophthalmic vein or cavernous sinus. | Veins, Retinal|Structure of central vein of the retina (body structure)|Retinal Veins|CRV - Central retinal vein|Vein, Central Retinal|vein retinal|Structure of retinal vein (body structure)|Vena centralis retinae|central retinal vein|Central Retinal Veins|Vein, Retinal|retinal vein|V. centralis retinae|central vein retinal|Veins, Central Retinal|Retinal Vein, Central|Retinal vein, NOS|Structure of retinal vein|Retinal Veins, Central|Retinal vein|Central retinal vein|Retinal Vein|Central vein of the retina|Central Retinal Vein|Structure of central vein of the retina | Structure of central vein of the retina |
C0017601 | An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) | GLAUCOMA|Glaucomas|Glaucoma syndrome|Glaucoma, NOS|Glaucoma|GLAUCOMAS|Glaucoma (disorder)|Unspecified glaucoma|glaucoma|glaucomas | Glaucoma |
C0595921 | null | INTRAOCULAR PRESSURE|Disorder of intraocular pressure|pressure in eye|Disorder of intraocular pressure (disorder)|intraocular pressure | Intraocular pressure disorder |
C0042798 | Vision considered to be inferior to normal vision as represented by accepted standards of acuity, field of vision, or motility. Low vision generally refers to visual disorders that are caused by diseases that cannot be corrected by refraction (e.g., MACULAR DEGENERATION; RETINITIS PIGMENTOSA; DIABETIC RETINOPATHY, etc.). | Vision, Diminished|dimming vision|Visual impairment|Low vision|Vision, Reduced|low vision|Decreased vision|DIMINISHED VISION|Reduced Vision|Low vision, NOS|loss of vision|Vision, Low|Vision, Subnormal|Loss of eyesight|Diminished Vision|Darkened vision|Dim vision|Poor vision|dim vision|Dim vision (disorder)|VISION DIM|Subnormal Vision|Low Vision|Reduced vision | Low Vision |
C0197526 | null | Cyclodialysis|Separation of ciliary body|Cyclodialysis (procedure)|Cyclodialysis, NOS|Heine operation|cyclodialysis | Cyclodialysis |
C0184661 | In medicine, a treatment or action taken to prevent or treat disease, or improve health in other ways. | interventional procedure|Interventional|interventionDescription|Intervention or procedure|procedure|PROCEDURES|Intervention or Procedure|interventional procedures|Intervention Strategies|Procedure Axis|Procedure|intervention|PROCEDURES: GENERAL TERMS|Procedure, NOS|Intervention|Procedure (procedure)|Procedures | Interventional procedure |
C0332207 | null | Acinar (qualifier value)|acinar|Acinar | Acinar |
C0015283 | Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE. | vesicle exocytosis|Exocytosis|exocytosis | Exocytosis |
C0023630 | Study of the principles and practices of library administration and services. | Science, Library|Library science|Library Science|Library Sciences|Sciences, Library | Library Science |
C0023630 | Study of the principles and practices of library administration and services. | Science, Library|Library science|Library Science|Library Sciences|Sciences, Library | Library Science |
C0021665 | A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. | Insulin Like Growth Factor I|IGF-1|insulin like growth factor i|Insulin-Like Somatomedin Peptide I|somatomedin c|insulin-like growth factor 1 (IGF-1)|igf i|igf-i|IGF I|Insulin Like Somatomedin Peptide I|SmC - Somatomedin C|Somatomedin C|SM-C|Insulin-like growth factor 1|igf 1|IGF-I|insulin-like growth factor 1|igf-1|Somatomedin C (substance)|IGF-I-SmC|IGF 1 - Insulin like growth factor 1|Insulin-Like Growth Factor I|insulin like growth factor 1|Insulin-like growth factor I|insulin-like growth factor i|Human somatomedin C | Insulin-Like Growth Factor I |
C0021666 | A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. | insulin-like growth factor 2|SM-A|Multiplication Stimulating Activity|IGF-II|igf-2|Insulin-Like Growth Factor II|Insulin-like growth factor 2|igf 2|IGF II|Insulin-Like Somatomedin Peptide II|Somatomedin A|Multiplication-Stimulating Activity|Multiplication Stimulating Factor|Somatomedin A (substance)|insulin-like growth factor ii|Factor, Multiplication-Stimulating|Insulin-like growth factor II|Somatomedin MSA|Insulin Like Somatomedin Peptide II|Multiplication-Stimulating Factor|IGF 2 - Insulin-like growth factor 2|igf-ii|Insulin Like Growth Factor II|IGF-2 | insulin-like growth factor 2 |
C0063082 | null | null | hydroethidine |